mhurhangee/patent-ind-claim-en huggingface dataset:
An aircraft comprising: an aircraft cargo roller panel configured to facilitate loading aircraft cargo into a compartment of the aircraft , said aircraft cargo roller panel including one or more motive devices that are configured to engage the cargo to move it within the compartment ; a plurality of load cells coupled to the aircraft cargo roller panel , each load cell of the plurality of load cells being configured to generate a load signal indicative of a load experienced by the load cell when the cargo is on the aircraft cargo roller panel ; and a controller configured to receive load signals from the plurality of load cells and to determine, based on the load signals , a weight of the cargo , a center of gravity of the cargo , or both, said controller being further configured to: perform a comparison of the weight of the cargo , the center of gravity of the cargo , or both to acceptance criteria; and based on a result of the comparison, determine whether to accept the cargo , in response to accepting the cargo , the controller being configured to generate a control signal to enable the motive devices to engage the cargo and transport it within the compartment , the control signal being generated responsive to the load signals , said controller being configured to generate an override prompt based on a determination by the controller that the cargo is not accepted, wherein the override prompt enables a user to provide user credentials and to identify the cargo as accepted. an aircraft cargo roller panel configured to facilitate loading aircraft cargo into a compartment of the aircraft , said aircraft cargo roller panel including one or more motive devices that are configured to engage the cargo to move it within the compartment ; a plurality of load cells coupled to the aircraft cargo roller panel , each load cell of the plurality of load cells being configured to generate a load signal indicative of a load experienced by the load cell when the cargo is on the aircraft cargo roller panel ; and a controller configured to receive load signals from the plurality of load cells and to determine, based on the load signals , a weight of the cargo , a center of gravity of the cargo , or both, said controller being further configured to: perform a comparison of the weight of the cargo , the center of gravity of the cargo , or both to acceptance criteria; and based on a result of the comparison, determine whether to accept the cargo , perform a comparison of the weight of the cargo , the center of gravity of the cargo , or both to acceptance criteria; and based on a result of the comparison, determine whether to accept the cargo , in response to accepting the cargo , the controller being configured to generate a control signal to enable the motive devices to engage the cargo and transport it within the compartment , the control signal being generated responsive to the load signals , said controller being configured to generate an override prompt based on a determination by the controller that the cargo is not accepted, wherein the override prompt enables a user to provide user credentials and to identify the cargo as accepted.
A method for managing content transmission based on data rates, characterized by : determining, by a computing device, based on a first data rate, and based on a first expected number of packet retransmissions at the first data rate, a first expected time of transmission of a content item; determining, by the computing device, based on a second data rate that is lower than the first data rate, and based on a second expected number of packet retransmissions at the second data rate, a second expected time of transmission for the content item; determining, by the computing device and based on a comparison of the first expected time and the second expected time, to transmit the content item at the second data rate; and transmitting, by the computing device and based on the second data rate, the content item. determining, by a computing device, based on a first data rate, and based on a first expected number of packet retransmissions at the first data rate, a first expected time of transmission of a content item; determining, by the computing device, based on a second data rate that is lower than the first data rate, and based on a second expected number of packet retransmissions at the second data rate, a second expected time of transmission for the content item; determining, by the computing device and based on a comparison of the first expected time and the second expected time, to transmit the content item at the second data rate; and transmitting, by the computing device and based on the second data rate, the content item.
A roll-up bag awning with an awning shaft arranged at the end, characterized in that the awning shaft has a device on at least one end face for rolling up the fabric panel of the awning, wherein the device is manually operated, wherein the device comprises a gear mechanism , wherein the gear mechanism is connected to an adapter which is rotatable relative to the gear mechanism , wherein the adapter is connected in a rotationally fixed manner to the awning shaft , wherein the gear mechanism is manually drivable by a crank handle.
A combination of Lactobacillus rhamnosus and Bifidobacterium animalis subsp. lactis for use in reducing the duration and/or the severity of upper respiratory tract infection (URI) in teenagers and adults having upper respiratory tract infection (URI).
An unmanned carrier vehicle , comprising: a vehicle body ; a plurality of wheels attached to the vehicle body ; a steering actuator for adjusting a steering angle of each of the wheels , the vehicle characterised in that a cargo section is arranged movably on the vehicle body in planar view; and a control unit is configured to output an instruction for moving the cargo section , when adjustment of the steering angle is performed at least in a state that the vehicle body remains stopped, to reduce a load acting on one or more target wheels each being an adjustment target for the steering angle with the steering actuator among the plurality of wheels . a vehicle body ; a plurality of wheels attached to the vehicle body ; a steering actuator for adjusting a steering angle of each of the wheels , the vehicle characterised in that a cargo section is arranged movably on the vehicle body in planar view; and a control unit is configured to output an instruction for moving the cargo section , when adjustment of the steering angle is performed at least in a state that the vehicle body remains stopped, to reduce a load acting on one or more target wheels each being an adjustment target for the steering angle with the steering actuator among the plurality of wheels .
A railway vehicle , comprising: an air conditioner for generating conditioned air whose temperature and humidity are conditioned; and a duct for supplying the conditioned air to inside of the vehicle, wherein: the duct forms a flow channel having a geometrical shape in an overhead view having a center portion and is made up of a channel element having an opening facing toward a ceiling panel arranged below a roof structure body of the railway vehicle, and the ceiling panel provided to cover the opening; and in the duct , an ejection port through which conditioned air flowing through the duct is ejected transversely to the direction of flow in the duct in a substantially horizontal direction toward the center portion is provided between the channel element and the ceiling panel . an air conditioner for generating conditioned air whose temperature and humidity are conditioned; and a duct for supplying the conditioned air to inside of the vehicle, wherein: the duct forms a flow channel having a geometrical shape in an overhead view having a center portion and is made up of a channel element having an opening facing toward a ceiling panel arranged below a roof structure body of the railway vehicle, and the ceiling panel provided to cover the opening; and in the duct , an ejection port through which conditioned air flowing through the duct is ejected transversely to the direction of flow in the duct in a substantially horizontal direction toward the center portion is provided between the channel element and the ceiling panel . the duct forms a flow channel having a geometrical shape in an overhead view having a center portion and is made up of a channel element having an opening facing toward a ceiling panel arranged below a roof structure body of the railway vehicle, and the ceiling panel provided to cover the opening; and a channel element having an opening facing toward a ceiling panel arranged below a roof structure body of the railway vehicle, and the ceiling panel provided to cover the opening; and in the duct , an ejection port through which conditioned air flowing through the duct is ejected transversely to the direction of flow in the duct in a substantially horizontal direction toward the center portion is provided between the channel element and the ceiling panel .
An agitator assembly for a blending container , comprising: an agitator nut configured to secure the agitator assembly to the blending container ; an agitator base including at least one agitator blade mounted thereon and configured to be seated in the agitator nut prior to the agitator assembly being secured to the blending container ; characterized by a groove formed in an inner wall of the agitator nut ; and a seal having an outer periphery that when inserted into the groove secures the agitator base into the agitator nut . an agitator nut configured to secure the agitator assembly to the blending container ; an agitator base including at least one agitator blade mounted thereon and configured to be seated in the agitator nut prior to the agitator assembly being secured to the blending container ; characterized by a groove formed in an inner wall of the agitator nut ; and a seal having an outer periphery that when inserted into the groove secures the agitator base into the agitator nut .
A 5-aminopyrazole carboxamide compound represented by the formula (IV): wherein, L is O, -C(O)NH-, -CH 2 -, S, S(O), NH or S(O) 2 ; A is selected from a substituted or unsubstituted benzene ring, or a substituted or unsubstituted heteroaryl ring, and its attachment sites to the parent nucleus and L are arbitrarily selected; B is independently selected from a substituted or unsubstituted benzene ring, or a substituted or unsubstituted heteroaryl ring, and its attachment site to L is arbitrarily selected; Y is -CN, wherein R 3 , R 4 , R 5 and R 6 are each independently selected from hydrogen, unsubstituted C 1 -C 4 alkyl, hydroxy-substituted C 1 -C 4 alkyl, C 1 -C 4 alkoxy C 1 -C 4 alkyl, halogen, cyano or -(CH 2 ) q N(R a R b ), wherein q is 1, 2, 3, or 4, and R a and R b are each independently selected from hydrogen, or unsubstituted C 1 -C 4 alkyl; or a stereoisomer, a tautomer, a pharmaceutically acceptable salt, or a solvate thereof. L is O, -C(O)NH-, -CH 2 -, S, S(O), NH or S(O) 2 ; A is selected from a substituted or unsubstituted benzene ring, or a substituted or unsubstituted heteroaryl ring, and its attachment sites to the parent nucleus and L are arbitrarily selected; B is independently selected from a substituted or unsubstituted benzene ring, or a substituted or unsubstituted heteroaryl ring, and its attachment site to L is arbitrarily selected; Y is -CN, wherein R 3 , R 4 , R 5 and R 6 are each independently selected from hydrogen, unsubstituted C 1 -C 4 alkyl, hydroxy-substituted C 1 -C 4 alkyl, C 1 -C 4 alkoxy C 1 -C 4 alkyl, halogen, cyano or -(CH 2 ) q N(R a R b ), wherein q is 1, 2, 3, or 4, and R a and R b are each independently selected from hydrogen, or unsubstituted C 1 -C 4 alkyl; or a stereoisomer, a tautomer, a pharmaceutically acceptable salt, or a solvate thereof.
Sorting installation , in particular for transporting and/or sorting items to be conveyed , having: - at least one transport path , having at least one local stator , - at least one transport unit , having: - at least one conveyor element , in particular for loading and/or unloading items to be conveyed , - at least one conveyor rotor with at least one permanent magnet , preferably a plurality of permanent magnets , for driving the conveyor element , - wherein the transport unit is embodied to move on the transport path in a movement direction , - wherein the conveyor rotor is embodied to rotate about an axis of rotation (R) when the conveyor rotor interacts electromagnetically with the local stator , characterised in that the transport path has at least one latching apparatus , which is embodied such that a detent torque acts on the conveyor rotor when the conveyor rotor interacts electromagnetically with the latching apparatus . - at least one transport path , having at least one local stator , - at least one transport unit , having: - at least one conveyor element , in particular for loading and/or unloading items to be conveyed , - at least one conveyor rotor with at least one permanent magnet , preferably a plurality of permanent magnets , for driving the conveyor element , - at least one conveyor element , in particular for loading and/or unloading items to be conveyed , - at least one conveyor rotor with at least one permanent magnet , preferably a plurality of permanent magnets , for driving the conveyor element , - wherein the transport unit is embodied to move on the transport path in a movement direction , - wherein the conveyor rotor is embodied to rotate about an axis of rotation (R) when the conveyor rotor interacts electromagnetically with the local stator ,
A peptide consisting of a length of up to 40 amino acid residues, the peptide comprising an amino acid sequence K-X1-X2-X3-X4-X5-K-X6-X7-X8-X9-X10-X11-X12-X13-K (SEQ ID NO:2), wherein X1 and X13 are both cysteine residues and wherein the amino acid sequence set forth in SEQ ID NO:2 shares at least 80% identity with SEQ ID NO: 3 over the entire length of the sequence.
A binding moiety-drug conjugate (SDC-TRAP) comprising a binding moiety and an effector moiety, wherein the binding moiety is an Hsp90 inhibitor, wherein the effector moiety is a cytotoxic agent, said cytotoxic agent is flavopiridol, and wherein the binding moiety and the effector moiety are covalently attached.
An isolated, a synthetic or recombinant polypeptide capable of inhibiting the binding between leptin and NRP-1 consisting of an amino acid sequence of SEQ ID NO:3 (ENLRDLLHVLAFSKSCHLPWASGLETL) or SEQ ID NO:4 (EGNKPVLFQGNTNPTDVVVAVFPK).
A method of forming a display comprising: planarising a backplane comprising a plurality of backplane electrical contacts to provide a first planarised surface; planarising a monolithic light emitting diode structure comprising a plurality of electrical contacts corresponding to the plurality of electrical contacts of the backplane to provide a second planarised surface; bonding the first planarised surface to the second planarised surface, wherein bonding comprises forming a reversible bond between at least one of the plurality of backplane electrical contacts and a corresponding electrical contact of the monolithic light emitting diode structure; and subsequently selectively etching the monolithic light emitting diode structure to provide a plurality of physically isolated light emitting diode dies, thereby to enable removal and/or replacement of at least one physically isolated light emitting diode die by reversing the reversible bond between the at least one of the plurality of backplane electrical contacts and the corresponding electrical contact of the monolithic light emitting diode structure. planarising a backplane comprising a plurality of backplane electrical contacts to provide a first planarised surface; planarising a monolithic light emitting diode structure comprising a plurality of electrical contacts corresponding to the plurality of electrical contacts of the backplane to provide a second planarised surface; bonding the first planarised surface to the second planarised surface, wherein bonding comprises forming a reversible bond between at least one of the plurality of backplane electrical contacts and a corresponding electrical contact of the monolithic light emitting diode structure; and subsequently selectively etching the monolithic light emitting diode structure to provide a plurality of physically isolated light emitting diode dies, thereby to enable removal and/or replacement of at least one physically isolated light emitting diode die by reversing the reversible bond between the at least one of the plurality of backplane electrical contacts and the corresponding electrical contact of the monolithic light emitting diode structure.
A modified release solid oral composition, wherein said composition is a tablet, comprising a core and from 5 mg/cm 2 to 25 mg/cm 2 of an enteric coating, wherein: (a) the core comprises: (i) an effective amount of active pharmaceutical ingredient, wherein the active pharmaceutical ingredient is a peptide of 500 Da to 10,000 Da, (ii) a pH lowering agent selected from citric acid, tartaric acid and a combination thereof, (iii) an absorption enhancer comprising a cationic surface active agent, an anionic surface active agent or a combination thereof, wherein the absorption enhancer has a critical micelle concentration of from 1.0 mM to 40 mM, (iv) a filler comprising a hydrogel-forming polymer selected from hydroxypropylcellulose (HPC), hydroxypropylmethylcellulose (HPMC) or a combination thereof, wherein a 2% solution of the hydrogel-forming polymer has a viscosity between 3,000 to 120,000 cP at 20°C, and optionally (v) a pharmaceutically acceptable disintegrant, present at less than 0.01% by weight of the tablet; and (b) the enteric coating surrounds the core, wherein the composition provides a pharmacokinetic profile for the active agent with a T lag greater than 1.0 h and less than 16 h post-administration and a T max greater than (T lag +0.5 h) and less than 20 h post-administration at a fasted state. (a) the core comprises: (i) an effective amount of active pharmaceutical ingredient, wherein the active pharmaceutical ingredient is a peptide of 500 Da to 10,000 Da, (ii) a pH lowering agent selected from citric acid, tartaric acid and a combination thereof, (iii) an absorption enhancer comprising a cationic surface active agent, an anionic surface active agent or a combination thereof, wherein the absorption enhancer has a critical micelle concentration of from 1.0 mM to 40 mM, (iv) a filler comprising a hydrogel-forming polymer selected from hydroxypropylcellulose (HPC), hydroxypropylmethylcellulose (HPMC) or a combination thereof, wherein a 2% solution of the hydrogel-forming polymer has a viscosity between 3,000 to 120,000 cP at 20°C, and optionally (v) a pharmaceutically acceptable disintegrant, present at less than 0.01% by weight of the tablet; and (i) an effective amount of active pharmaceutical ingredient, wherein the active pharmaceutical ingredient is a peptide of 500 Da to 10,000 Da, (ii) a pH lowering agent selected from citric acid, tartaric acid and a combination thereof, (iii) an absorption enhancer comprising a cationic surface active agent, an anionic surface active agent or a combination thereof, wherein the absorption enhancer has a critical micelle concentration of from 1.0 mM to 40 mM, (iv) a filler comprising a hydrogel-forming polymer selected from hydroxypropylcellulose (HPC), hydroxypropylmethylcellulose (HPMC) or a combination thereof, wherein a 2% solution of the hydrogel-forming polymer has a viscosity between 3,000 to 120,000 cP at 20°C, and optionally (v) a pharmaceutically acceptable disintegrant, present at less than 0.01% by weight of the tablet; and (b) the enteric coating surrounds the core,
A method for wireless communication, the method performed by a user equipment, UE , the method comprising: establishing a connection with a base station using a primary component carrier, CC, , the primary CC having a plurality of bandwidth parts, BWPs, each having a portion of a frequency bandwidth of the primary CC ; receiving , from the base station , first downlink control information, DCI , on the primary CC , the first DCI including an indication to activate a first BWP of a plurality of BWPs of a secondary CC , each of the plurality of BWPs of the secondary CC having a portion of a frequency bandwidth of the secondary CC , the first DCI excluding a grant of resources of the first BWP for the UE , and wherein the first BWP is a dormant BWP, whereby the dormant BWP is a BWP with null attributes; activating the first BWP based at least in part on the first DCI ; and receiving , from the base station , a second DCI including an indication to switch from the first BWP to a second BWP of the plurality of BWPs, the second DCI excluding a grant of resources of the second BWP for the UE . establishing a connection with a base station using a primary component carrier, CC, , the primary CC having a plurality of bandwidth parts, BWPs, each having a portion of a frequency bandwidth of the primary CC ; receiving , from the base station , first downlink control information, DCI , on the primary CC , the first DCI including an indication to activate a first BWP of a plurality of BWPs of a secondary CC , each of the plurality of BWPs of the secondary CC having a portion of a frequency bandwidth of the secondary CC , the first DCI excluding a grant of resources of the first BWP for the UE , and wherein the first BWP is a dormant BWP, whereby the dormant BWP is a BWP with null attributes; activating the first BWP based at least in part on the first DCI ; and receiving , from the base station , a second DCI including an indication to switch from the first BWP to a second BWP of the plurality of BWPs, the second DCI excluding a grant of resources of the second BWP for the UE .
2'-O-Fucosyllactose (2'FL) hydrate with molecular formula C 18 H 32 O 15 *nH 2 O wherein n is a number in the range between 1 and 3; in crystalline form of polymorph A, with n being 3/2, wherein said polymorph A is 2'FL-3/2 H 2 O, having characteristic XRPD peaks at 9.89±0.20, 17.05±0.20, 18.86±0.20 2Θ; or in crystalline form of polymorph B, with n being 5/2, wherein said polymorph B is 2'FL-5/2 H 2 O, having characteristic XRPD peaks at 9.96±0.20, 11.90±0.20, 20.48±0.20 2Θ; wherein the measurements are made using Cu-K-alpha radiation (lambda = 1,5418) in the range 2Θ 4 to 60 °. wherein n is a number in the range between 1 and 3; in crystalline form of polymorph A, with n being 3/2, wherein said polymorph A is 2'FL-3/2 H 2 O, having characteristic XRPD peaks at 9.89±0.20, 17.05±0.20, 18.86±0.20 2Θ; or in crystalline form of polymorph B, with n being 5/2, wherein said polymorph B is 2'FL-5/2 H 2 O, having characteristic XRPD peaks at 9.96±0.20, 11.90±0.20, 20.48±0.20 2Θ; wherein the measurements are made using Cu-K-alpha radiation (lambda = 1,5418) in the range 2Θ 4 to 60 °.